
|
Effect
of Adherence to Newly Initiated Antiretroviral Therapy on Plasma
Viral Load [Gross R et al. AIDS 2001;15:2109] This
is of the results of an observational cohort study monitoring adherence
using the MEMS with 41 participants who initiated HAART in HIV clinics
in Philadelphia. The primary outcome was no detectable virus with
<50 c/ml at four months. Adherence was increased in those who
achieved the virologic goal with a median compliance of 93% to prescribed
doses. By contrast, those who did not achieve undetectable virus
took a median of 70% of doses. Adherence correlated with viral load
and CD4 count increase.
Comment: No surprises here, but the 90-95% rule seems to
be pretty well established with the current meds.
posted 3/12/2002

|

|